Information Provided By: 
Fly News Breaks for July 22, 2019
MCK
Jul 22, 2019 | 06:50 EDT
JPMorgan analyst Lisa Gill reinstated coverage of McKesson with an Overweight rating and $164 price target following a period of restriction. The rating is unchanged and the price target is raised from $160. The fundamentals of the company's core U.S. pharma distribution business appear to be stabilizing, while many of the prior company-specific headwinds have now cycled, Fill tells investors in a research note. Further, she believes McKesson should benefit from ongoing cost management efforts.
News For MCK From the Last 2 Days
